{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T06:16:54Z","timestamp":1774419414626,"version":"3.50.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Neuroscience"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.mcn.2008.04.012","type":"journal-article","created":{"date-parts":[[2008,5,11]],"date-time":"2008-05-11T04:18:24Z","timestamp":1210479504000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: Restoration by the neuroprotective compound CEP-1347"],"prefix":"10.1016","volume":"39","author":[{"given":"Paola","family":"Conforti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara L.","family":"Apostol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle A.","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huu Phuc","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olaf","family":"Riess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie Michels","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Zuccato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcn.2008.04.012_bib1","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/39885","article-title":"Anterograde transport of brain-derived neurotrophic factor and its role in the brain","volume":"389","author":"Altar","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.mcn.2008.04.012_bib2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.21139","article-title":"Mouse and rat BDNF gene structure and expression revisited","volume":"85","author":"Aid","year":"2007","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.mcn.2008.04.012_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcn.2008.04.007","article-title":"CEP-1347 reduces mutant huntingtin-associated neurotoxicity and restores brain derived neurotrophic factor levels in R6\/2 mice","author":"Apostol","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.mcn.2008.04.012_bib4","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1523\/JNEUROSCI.3920-03.2004","article-title":"Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor","volume":"24","author":"Baquet","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2008.04.012_bib5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/j.1460-2075.1982.tb01207.x","article-title":"Purification of a new neurotrophic factor from mammalian brain","volume":"1","author":"Barde","year":"1982","journal-title":"EMBO J."},{"key":"10.1016\/j.mcn.2008.04.012_bib6","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1172\/JCI27607","article-title":"Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase","volume":"116","author":"Borrell-Pages","year":"2006","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mcn.2008.04.012_bib7","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2008.04.012_bib8","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ajmg.b.30501","article-title":"Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients","volume":"144","author":"Ciammola","year":"2007","journal-title":"Am. J. Med. Genet., B Neuropsychiatr. Genet."},{"key":"10.1016\/j.mcn.2008.04.012_bib9","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1055\/s-0037-1613072","article-title":"Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation","volume":"87","author":"Fujimura","year":"2002","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.mcn.2008.04.012_bib44","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2008.04.012_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1365-3083.2003.01260.x","article-title":"Increased brain-derived neurotrophic factor expression in white blood cells of relapsing\u2013remitting multiple sclerosis patients","volume":"57","author":"Gielen","year":"2003","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.mcn.2008.04.012_bib45","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/01.wco.0000186842.51129.cb","article-title":"Biomarkers for neurodegenerative diseases","volume":"18","author":"Henley","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.mcn.2008.04.012_bib11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0165-1781(02)00005-7","article-title":"Decreased serum brain-derived neurotrophic factor levels in major depressed patients","volume":"109","author":"Karege","year":"2002","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.mcn.2008.04.012_bib12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1084\/jem.189.5.865","article-title":"Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?","volume":"189","author":"Kerschensteiner","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.mcn.2008.04.012_bib13","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1046\/j.1471-4159.1999.0721930.x","article-title":"Brain-derived neurotrophic factor levels in the nervous system of wild-type and neurotrophin gene mutant mice","volume":"72","author":"Kolbeck","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2008.04.012_bib14","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0002-9440(10)65221-2","article-title":"Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived neurotrophic functions","volume":"155","author":"Lommatzsch","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.mcn.2008.04.012_bib15","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.rmed.2007.01.003","article-title":"Platelet and plasma BDNF in lower respiratory tract infections of the adult","volume":"101","author":"Lommatzsch","year":"2007","journal-title":"Respir. Med."},{"key":"10.1016\/j.mcn.2008.04.012_bib16","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","article-title":"Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of huntington's disease","volume":"27","author":"Lynch","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2008.04.012_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.mcn.2008.04.012_bib18","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0301-0082(00)00014-9","article-title":"Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease","volume":"63","author":"Murer","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.mcn.2008.04.012_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0014-5793(00)01302-8","article-title":"Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor","volume":"470","author":"Nakahashi","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.mcn.2008.04.012_bib20","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1093\/hmg\/ddl394","article-title":"Behavioral abnormalities precede neuropathological markers in rats transgenic for Huntington's disease","volume":"15","author":"Nguyen","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2008.04.012_bib21","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/S0028-3908(98)00141-5","article-title":"Transport of brain-derived neurotrophic factor across the blood-brain barrier","volume":"37","author":"Pan","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mcn.2008.04.012_bib22","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1212\/01.WNL.0000103882.56507.20","article-title":"The safety and tolerability of a mixed lineage kinase inhibitor (CEP-1347) in PD","volume":"62","author":"Parkinson Study Group","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2008.04.012_bib23","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/01.wnl.0000277648.63931.c0","article-title":"Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease","volume":"69","author":"Parkinson Study Group PRECEPT Investigators","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2008.04.012_bib24","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0306-4522(98)00723-4","article-title":"Brain-derived neurotrophic factor, neurotrophin-3 and neurotrophin-4\/5 differentially regulate the phenotype and prevent degenerative changes in striatal projection neurons after excitotoxicity in vivo","volume":"91","author":"Perez-Navarro","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.mcn.2008.04.012_bib25","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1046\/j.1471-4159.2000.0752190.x","article-title":"Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4\/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease","volume":"75","author":"Perez-Navarro","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.mcn.2008.04.012_bib26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0006-8993(95)01321-0","article-title":"Presence of brain-derived neurotrophic factor in brain and human and rat but not mouse serum detected by a sensitive and specific immunoassay","volume":"709","author":"Radka","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.mcn.2008.04.012_bib27","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mcn.2008.04.012_bib28","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1212\/01.WNL.0000065888.88988.6E","article-title":"Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis","volume":"60","author":"Rosas","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2008.04.012_bib29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1212\/01.wnl.0000174432.87383.87","article-title":"Regional cortical thinning in preclinical Huntington disease and its relationship to cognition","volume":"65","author":"Rosas","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.mcn.2008.04.012_bib30","doi-asserted-by":"crossref","first-page":"24554","DOI":"10.1074\/jbc.M609885200","article-title":"Loss of huntingtin function complemented by small molecules acting as repressor element 1\/neuron restrictive silencer element silencer modulators","volume":"282","author":"Rigamonti","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2008.04.012_bib31","doi-asserted-by":"crossref","first-page":"49473","DOI":"10.1074\/jbc.M203428200","article-title":"K252a and CEP1347 are neuroprotective compounds that inhibit mixed-lineage kinase-3 and induce activation of Akt and ERK","volume":"277","author":"Roux","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mcn.2008.04.012_bib32","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0022-3565(24)37972-8","article-title":"CEP-1347\/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons in vivo","volume":"288","author":"Saporito","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.mcn.2008.04.012_bib33","doi-asserted-by":"crossref","first-page":"11758","DOI":"10.1523\/JNEUROSCI.2461-07.2007","article-title":"Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration","volume":"27","author":"Strand","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.mcn.2008.04.012_bib35","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.mcn.2008.04.012_bib36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ng0595-104","article-title":"Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form","volume":"10","author":"Trottier","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mcn.2008.04.012_bib37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/hmg\/ddg075","article-title":"Transgenic rat model of Huntington's disease","volume":"12","author":"von H\u00f6rsten","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.mcn.2008.04.012_bib38","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.bcp.2006.06.031","article-title":"Recent clinical failures in Parkinson's disease with apoptosis inhibitors underline the need for a paradigm shift in drug discovery for neurodegenerative diseases","volume":"72","author":"Waldmeier","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.mcn.2008.04.012_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1146\/annurev.pharmtox.44.101802.121840","article-title":"Mixed-lineage kinases: a target for the prevention of neurodegeneration","volume":"44","author":"Wang","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.mcn.2008.04.012_bib40","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.mcn.2008.04.012_bib41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","article-title":"Role of brain-derived neurotrophic factor in Huntington's disease","volume":"81","author":"Zuccato","year":"2007","journal-title":"Prog. Neurobiol"},{"key":"10.1016\/j.mcn.2008.04.012_bib42","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","article-title":"Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery","volume":"52","author":"Zuccato","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mcn.2008.04.012_bib43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","article-title":"Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease","volume":"18","author":"Zuccato","year":"2008","journal-title":"Brain Pathol."}],"container-title":["Molecular and Cellular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743108001048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044743108001048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T01:03:41Z","timestamp":1760922221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044743108001048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S1044743108001048"],"URL":"https:\/\/doi.org\/10.1016\/j.mcn.2008.04.012","relation":{},"ISSN":["1044-7431"],"issn-type":[{"value":"1044-7431","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: Restoration by the neuroprotective compound CEP-1347","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcn.2008.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}